Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases

Andrea Ruzzenente, Fabio Bagante, Francesca Ratti, Eliza W. Beal, Sorin Alexandrescu, Katiuscha Merath, Eleftherios A. Makris, George A. Poultsides, Georgios A. Margonis, Matthew J. Weiss, Irinel Popescu, Luca Aldrighetti, Alfredo Guglielmi, Timothy M. Pawlik

Research output: Contribution to journalArticle

Abstract

Background: Progression of colorectal liver metastasis (CRLM) on preoperative chemotherapy has been associated with a worse prognosis compared with patients who have responsive disease. Defining response can be challenging as traditional criteria largely assess only tumor size. Methods: Patients who underwent hepatectomy between 2010 and 2017 were identified using a multi-centric database. This study aimed to define the impact of preoperative chemotherapy response relative to initial tumor burden score (TBS) and determine impact of clinico-pathological variables on overall survival (OS). Results: Among 784 patients who received preoperative chemotherapy, the regimen was oxaliplatin- (66%) or irinotecan-based (34%). Among patients with a TBS<6 at diagnosis, genetic status was the most important prognostic variable. Patients with a TBS<6, 5-year OS was 55%, 35%, and 0% for patients with KRAS/NRAS/BRAF wild-type, KRAS/NRAS, and BRAF mutations, respectively. Among patients who presented with CRLM with a TBS≥6, only Δ-TBS was prognostically important and patients with a Δ-TBS ≥ −10% had a 5-year OS of 27% compared with 49% for patients with a Δ-TBS < −10%. Conclusions: Prognostic stratification of patients with CRLM receiving preoperative chemotherapy should be multi-faceted and include consideration of initial tumor burden, change in tumor burden due to chemotherapy, and tumor genetic status.

Original languageEnglish (US)
Pages (from-to)1230-1239
Number of pages10
JournalHPB
Volume21
Issue number9
DOIs
StatePublished - Sep 2019

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases'. Together they form a unique fingerprint.

  • Cite this

    Ruzzenente, A., Bagante, F., Ratti, F., Beal, E. W., Alexandrescu, S., Merath, K., Makris, E. A., Poultsides, G. A., Margonis, G. A., Weiss, M. J., Popescu, I., Aldrighetti, L., Guglielmi, A., & Pawlik, T. M. (2019). Response to preoperative chemotherapy: impact of change in total burden score and mutational tumor status on prognosis of patients undergoing resection for colorectal liver metastases. HPB, 21(9), 1230-1239. https://doi.org/10.1016/j.hpb.2019.01.014